This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Treatment of Primary Menstrual Pain With Kanion Capsule

This study has been completed.
Information provided by:
Lianyungang Kanion Group, Ltd. Identifier:
First received: August 29, 2007
Last updated: February 2, 2010
Last verified: February 2010

The objectives of this clinical trial are:

  • To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
  • To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Condition Intervention Phase
Primary Dysmenorrhea Drug: Kanion Capsule Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial

Resource links provided by NLM:

Further study details as provided by Lianyungang Kanion Group, Ltd.:

Primary Outcome Measures:
  • pain reduction [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • accompanying symptoms improvement [ Time Frame: 6 months ]

Study Start Date: April 2007
Study Completion Date: February 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • primary dysmenorrhea

Exclusion Criteria:

  • secondary dysmenorrhea
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00523146

United States, Georgia
Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia, United States, 30328
Sponsors and Collaborators
Lianyungang Kanion Group, Ltd.
Study Chair: Jun Shao, Ph.D. Biokey Inc.
  More Information Identifier: NCT00523146     History of Changes
Other Study ID Numbers: GF-2006-001
Study First Received: August 29, 2007
Last Updated: February 2, 2010

Keywords provided by Lianyungang Kanion Group, Ltd.:
primary dysmenorrhea
Herbal remedy

Additional relevant MeSH terms:
Menstruation Disturbances
Pathologic Processes
Pelvic Pain
Neurologic Manifestations
Signs and Symptoms processed this record on September 19, 2017